Transplant Center Variability in Disparities for African-American Kidney Transplant Recipients

被引：0
|
作者：
Taber, D. [1 ]
Gebregziabher, M. [1 ]
Egede, L. [1 ]
Baliga, P. [1 ]
机构：
[1] MUSC, Charleston, SC USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
497
引用
收藏
页码：381 / 381
页数：1
相关论文
共 50 条
  • [1] Transplant Center Variability in Disparities for African-American Kidney Transplant Recipients
    Taber, David J.
    Gebregziabher, Mulugeta
    Srinivas, Titte
    Egede, Leonard E.
    Baliga, Prabhakar K.
    [J]. ANNALS OF TRANSPLANTATION, 2018, 23 : 119 - 128
  • [2] The Impact of Non-Adherence on Disparities in African-American Kidney Transplant Recipients.
    Taber, D.
    Chokkalingam, A.
    Posadas, A.
    Browning, R.
    Salazar, N.
    Kamel, M.
    Pullalarevu, R.
    Kadri, B.
    Srinivas, T.
    Chavin, K.
    Baliga, P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 518 - 519
  • [3] The Impact of Early versus Late Clinical Outcomes on Disparities in African-American Kidney Transplant Recipients.
    Taber, D.
    Fleming, J.
    Su, Z.
    Mauldin, P.
    McGillicuddy, J.
    Nadig, S.
    Rohan, V.
    Baliga, P.
    Dubay, D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 309 - 309
  • [4] Genotype-guided tacrolimus dosing in African-American kidney transplant recipients
    Sanghavi, K.
    Brundage, R. C.
    Miller, M. B.
    Schladt, D. P.
    Israni, A. K.
    Guan, W.
    Oetting, W. S.
    Mannon, R. B.
    Remmel, R. P.
    Matas, A. J.
    Jacobson, P. A.
    [J]. PHARMACOGENOMICS JOURNAL, 2017, 17 (01): : 61 - 68
  • [5] Induction therapy with basiliximab versus thymoglobulin in African-American kidney transplant recipients
    Haririan, A
    Morawski, K
    Sillix, DH
    El-Amm, JM
    Garnick, J
    West, MS
    Granger, DK
    Migdal, SD
    Gruber, SA
    [J]. TRANSPLANTATION, 2005, 79 (06) : 716 - 721
  • [6] Genotype-guided tacrolimus dosing in African-American kidney transplant recipients
    K Sanghavi
    R C Brundage
    M B Miller
    D P Schladt
    A K Israni
    W Guan
    W S Oetting
    R B Mannon
    R P Remmel
    A J Matas
    P A Jacobson
    [J]. The Pharmacogenomics Journal, 2017, 17 : 61 - 68
  • [7] Alemtuzumab Induction with Steroid-Free Maintenance in African-American Kidney Transplant Recipients
    Africa, J.
    Tucker, M. J.
    Orquiza, M.
    Ghasemian, S.
    Light, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 209 - 209
  • [8] Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients
    Taber, David J.
    McGillicuddy, John W.
    Bratton, Charles F.
    Rohan, Vinayak S.
    Nadig, Satish
    Dubay, Derek
    Baliga, Prabhakar K.
    [J]. ANNALS OF SURGERY, 2017, 266 (03) : 450 - 456
  • [9] Outcomes of African-American kidney-transplant recipients treated with sirolimus, tacrolimus, and corticosteroids
    Egidi, MF
    Gaber, AO
    [J]. TRANSPLANTATION, 2003, 75 (04) : 572 - 572
  • [10] Tacrolimus dose requirements in African-American and Caucasian kidney transplant recipients on mycophenolate and prednisone
    Beermann, Kristi J.
    Ellis, Matthew J.
    Sudan, Debra L.
    Harris, Matthew T.
    [J]. CLINICAL TRANSPLANTATION, 2014, 28 (07) : 762 - 767
12345